Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The India diabetes care devices market was valued at USD 5.90 Billion in 2025 and is expected to grow at a CAGR of 10.10%, reaching USD 15.44 Billion by 2035. The market growth is driven by the increasing burden of diabetes, improving healthcare accessibility, and rising adoption of affordable monitoring devices. The expansion of digital healthcare services and awareness programs is expected to drive market growth during the forecast period.
Compound Annual Growth Rate
10.1%
Value in USD Billion
2026-2035
Read more about this report - Request a Free Sample
Diabetes care devices are gaining wider acceptance as healthcare providers and patients increasingly recognize the value of accurate monitoring and effective disease management. Technology adoption continues to improve accessibility. The market was valued at USD 5.90 Billion in 2025. It is expanding due to the growing diabetic population, improving healthcare infrastructure, rising health awareness, and increasing availability of affordable diabetes management technologies.
|
Analysis Type |
Factors |
Example |
|
Market Drivers |
Affordable Continuous Glucose Monitoring Innovations Strengthen the Market Value |
In November 2025, IIT Madras patented a cost-effective, minimally invasive continuous glucose monitoring device to improve accessibility and affordability. |
|
Market Restraints |
Counterfeit Diabetes Devices Challenge Market Credibility and Patient Safety |
In June 2024, Roche reported counterfeit Accu-Chek glucose testing products online, raising safety concerns and reducing patient confidence. |
|
Market Opportunities |
Expansion of Artificial Intelligence-Enabled Healthcare Creates New Market Potential |
In February 2026, the Government of India highlighted AI-powered diabetic retinopathy screening, telemedicine, and wearable healthcare initiatives supporting adoption. |
The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.
Affordable Continuous Glucose Monitoring Innovations Strengthen the Market Value
The rising focus on affordable and minimally invasive glucose monitoring devices is accelerating the adoption of diabetes care devices across the market. Cost-effective innovations improve patient compliance, enable frequent glucose monitoring, and expand access to advanced diabetes management solutions. For instance, in November 2025, researchers at IIT Madras developed and patented a cost-effective, minimally invasive continuous glucose monitoring device featuring a reusable electronic module and disposable microneedle sensor patch, designed to enhance accessibility and long-term affordability. This advancement is expected to strengthen product adoption and support sustained market expansion.
Counterfeit Diabetes Devices Challenge Market Credibility and Patient Safety
The circulation of counterfeit diabetes care devices poses a significant challenge by undermining patient confidence, compromising treatment accuracy, and affecting the adoption of genuine products. For example, in June 2024, Roche alleged that counterfeit Accu-Chek glucose testing products with falsified labels and expiration dates were being sold through online channels, potentially providing inaccurate glucose readings and increasing health risks. Such incidents emphasize the need for stronger regulatory oversight and quality assurance, which may temporarily restrain market growth.
Expansion of Artificial Intelligence-Enabled Healthcare Creates New Market Potential
The increasing integration of artificial intelligence into diabetes diagnosis, monitoring, and remote healthcare is creating significant opportunities for advanced diabetes care devices. AI-driven technologies improve early disease detection, enable continuous monitoring, and enhance clinical decision-making. According to the Press Information Bureau (PIB), in February 2026, the Government of India highlighted the growing adoption of AI-powered healthcare initiatives, including diabetic retinopathy screening, AI-assisted telemedicine, and wearable health technologies. These initiatives are expected to accelerate the adoption of intelligent diabetes care devices and support long-term market development.
The market is witnessing several trends, including advanced insulin delivery devices and patient-centric diabetes management solutions.
Advancements in Patient-Centric Insulin Delivery Devices Are Elevating the Market Landscape
The growing emphasis on improving patient comfort, treatment adherence, and precise insulin administration is shaping the landscape. For instance, in November 2023, Terumo India introduced a sterile insulin syringe featuring a super-sharp needle design and plunger retention technology to improve comfort and minimize dosage wastage for patients requiring daily insulin therapy. Such product innovations are expected to encourage device adoption and contribute to sustained market growth.
Read more about this report - Request a Free Sample
Blood Glucose Monitoring Systems are Expected to Lead the Market Share by Product Type
The market is segmented into blood glucose monitoring systems, insulin delivery devices, diabetes management mobile applications. Blood glucose monitoring devices, particularly continuous glucose monitoring (CGM) systems, are expected to lead due to the increasing need for real-time glucose tracking, improved disease management, and enhanced patient convenience. For example, in March 2026, Zydus Lifesciences launched the AI-enabled Diasens and GlucoLive CGM devices, offering continuous glucose monitoring with remote care capabilities and artificial intelligence-driven insights. Such technological advancements are expected to accelerate CGM adoption and reinforce the segment's leading position in the market.
The key features of the market report include funding and investment analysis and strategic initiatives by leading players. The major companies in the market are as follows:
Abbott Laboratories is a major participant in the market through its FreeStyle Libre continuous glucose monitoring systems, including FreeStyle Libre 2 and FreeStyle Libre 3. These sensor-based devices provide real-time glucose readings and smartphone connectivity, supporting better diabetes management. Abbott’s continuous glucose monitoring technology strengthens its role in advancing connected and patient-focused diabetes care solutions.
Becton, Dickinson and Company is a long-established participant in the market, with a diabetes care portfolio built around insulin injection technologies. The company’s diabetes business, known for specialized insulin syringes and related injection devices, continues to support safe and efficient insulin administration. Its ongoing focus on diabetes care innovation reinforces BD’s presence in the global and Indian diabetes device sector.
Eli Lilly and Company supports diabetes management through insulin-based treatment approaches and digital care initiatives for people living with Type 1 and Type 2 diabetes. The company emphasizes integrated diabetes support, including medication management, lifestyle guidance, and connected care resources. Lilly’s continued focus on diabetes solutions contributes to the broader India diabetes care devices market by encouraging comprehensive diabetes management practices.
Insulet Corporation is an innovative diabetes technology company recognized for its Omnipod 5 Automated Insulin Delivery System and Omnipod Discover data management platform. The wearable, tubeless insulin pump integrates with continuous glucose monitoring systems to automate insulin delivery and improve glycemic control. Insulet’s advanced insulin delivery and diabetes data management technologies support the evolution of modern diabetes care devices relevant to the market.
Other key players in the market include Ascensia Diabetes Care Holdings AG, DexCom, Inc., F. Hoffmann-La Roche AG, Medtronic PLC, Novo Nordisk A/S, and Bionime Corporation.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
The market is segmented by product type, supported by the rapidly increasing diabetic population, improving healthcare accessibility, and growing adoption of affordable and technologically advanced diabetes management solutions.
Market Breakup by Disease Type
The market is segmented by disease type, driven by increasing disease awareness, rising diagnosis rates, and expanding government initiatives to strengthen chronic disease prevention and management.
Market Breakup by Patient Care Settings
The market is segmented by patient care settings, reflecting rising demand for accessible healthcare services, increasing preference for self-management solutions, and expanding availability of diabetes care across urban and rural settings.
This report is developed using a comprehensive mixed-methods research approach combining qualitative and quantitative analysis to evaluate the India Diabetes Care Devices Market.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Disease Type |
|
| Breakup by Patient Care Settings |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.